Antihypertensive Drugs for MRCP Part 1
- Crack Medicine
- Jan 19
- 3 min read
TL;DR
For MRCP Part 1, antihypertensive drugs are tested through mechanisms, predictable side effects, and classic contraindication-based traps rather than guideline sequencing. If you can link where a drug acts to what adverse effect it causes, most exam questions become straightforward. This guide distils the high-yield patterns, exam logic, and revision tactics you actually need.
Antihypertensive Drugs: Mechanisms & Side Effects (MRCP Part 1)
Why this topic matters
Antihypertensive pharmacology is a reliable scoring area in MRCP Part 1 because questions are highly patterned. The exam does not ask you to manage chronic hypertension in real life; instead, it expects you to recognise why a patient develops ankle oedema, hyperkalaemia, bradycardia, or acute kidney injury after starting a specific drug.
This topic integrates cardiovascular physiology, renal haemodynamics, and autonomic pharmacology. Candidates who revise it superficially often lose marks to avoidable traps. Those who revise it mechanistically usually gain them.
If you are building your revision from the main hub, start with the MRCP Part 1 overview and use this article as focused pharmacology support.
Exam scope: what MRCP Part 1 actually tests
Antihypertensive drugs appear in the exam under five consistent themes:
Mechanism of action
Characteristic side effects
Contraindications
Drug interactions
Recognition from short clinical vignettes
Exact blood pressure targets and treatment algorithms are not the focus. The emphasis is on cause-and-effect reasoning.
The five most tested antihypertensive drug classes
1. ACE inhibitors (e.g. ramipril, enalapril)
Mechanism Inhibit angiotensin-converting enzyme → reduced angiotensin II → efferent arteriolar dilation → reduced aldosterone.
High-yield side effects
Dry cough (bradykinin accumulation)
Hyperkalaemia
Rise in creatinine
Angioedema (rare but examinable)
Classic exam stem Diabetic patient with renal bruit who develops rising creatinine after starting treatment.
2. Angiotensin receptor blockers (ARBs)
Mechanism Block angiotensin II at the AT1 receptor.
Exam distinction
Similar renal and potassium effects to ACE inhibitors
No cough
Typical question ACE-inhibitor intolerance due to cough → switch to ARB.
3. Calcium channel blockers (CCBs)
Dihydropyridines (e.g. amlodipine)
Act mainly on vascular smooth muscle
Cause arteriolar vasodilation
Side effects
Ankle oedema
Flushing
Headache
Non-dihydropyridines (verapamil, diltiazem)
Act on myocardium and AV node
Side effects
Bradycardia
Heart block
Constipation (verapamil)
4. Beta-blockers
Mechanismβ-adrenergic receptor blockade → reduced heart rate and renin release.
High-yield adverse effects
Bronchospasm
Masking of hypoglycaemia
Erectile dysfunction
Bradycardia
Key contraindication
Asthma (especially with non-selective agents)
5. Diuretics
Thiazides
Act at distal convoluted tubule
Side effects
Hyponatraemia
Hypokalaemia
Hyperuricaemia
Hypercalcaemia
Loop diuretics
Act at loop of Henle
Side effects
Hypokalaemia
Metabolic alkalosis
Ototoxicity
High-yield comparison table
Drug class | Key side effect | Typical MRCP Part 1 clue |
ACE inhibitor | Cough | Persistent dry cough |
ARB | Hyperkalaemia | ACE-intolerant patient |
Amlodipine | Ankle oedema | Bilateral leg swelling |
Verapamil | Constipation | Bradycardia on ECG |
Beta-blocker | Bronchospasm | Wheeze after initiation |
Thiazide | Hyponatraemia | Confusion in elderly |
10 high-yield exam principles
ACE inhibitors dilate the efferent arteriole, lowering intraglomerular pressure.
A mild creatinine rise after ACE inhibitors is expected; a large rise suggests renal artery stenosis.
CCB-related ankle oedema is due to pre-capillary vasodilation, not fluid overload.
ARBs share potassium risks with ACE inhibitors.
Beta-blockers blunt adrenergic warning signs of hypoglycaemia.
Verapamil plus beta-blocker increases risk of complete heart block.
Thiazides raise calcium levels.
Loop diuretics are preferred in renal impairment.
ACE inhibitors and ARBs are contraindicated in pregnancy.
Side effects are more frequently tested than benefits.
Mini-case (exam style)
Question A 64-year-old man with hypertension and type 2 diabetes is started on a new medication. Two weeks later, his creatinine rises from 90 µmol/L to 140 µmol/L and potassium is 5.9 mmol/L. An abdominal bruit is noted.
Most likely drug? ACE inhibitor
Explanation Efferent arteriolar dilation reduces glomerular filtration pressure. In renal artery stenosis, this leads to a significant fall in GFR and hyperkalaemia due to reduced aldosterone.
Common exam pitfalls (and fixes)
Confusing CCB-induced oedema with heart failure
Forgetting potassium effects of ACE inhibitors and ARBs
Using beta-blockers in asthma
Assuming creatinine rise equals allergy
Ignoring dangerous drug combinations
Practical revision checklist
Revise antihypertensives by mechanism first
Attach one signature side effect to each class
Practise mixed pharmacology blocks via Free MRCP MCQs
Sit timed papers using mock tests
Re-review errors weekly — patterns repeat
FAQs
Do I need NICE hypertension guidelines for MRCP Part 1?
No. The exam prioritises pharmacology and adverse effects over treatment algorithms.
Why do ACE inhibitors increase creatinine?
They reduce efferent arteriolar tone, lowering glomerular filtration pressure.
Which antihypertensive causes ankle oedema?
Dihydropyridine calcium channel blockers such as amlodipine.
Are beta-blockers still tested?
Yes — particularly for contraindications, side effects, and interactions.
Ready to start?
Antihypertensive questions reward structured, mechanism-based thinking. Consolidate your cardiovascular pharmacology through the MRCP Part 1 overview, sharpen recall with Free MRCP MCQs, and pressure-test your understanding using full-length mock tests.
Sources
MRCP(UK) Examination Blueprinthttps://www.mrcpuk.org/mrcpuk-examinations/examination-blueprints
British National Formulary (BNF)https://bnf.nice.org.uk
Comments